R&D expenditure of CSL Limited FY 2015-2023
The 2023 financial year saw the research and development expenditure of Melbourne-based CSL Limited increase to over 1.2 billion U.S. dollars. CSL Limited is a global biotechnology company that is involved in the research, development, manufacturing, and marketing of products used to treat human medical conditions.